Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Extended Infusion Carfilzomib on a Weekly Schedule in Patients With Advanced Solid Malignancies

NCT02257476 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT02257476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02257476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Extended Infusion Carfilzomib on a Weekly Schedule in Patients With Advanced Solid Malignancies
Lead sponsor
Emory University
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2014
Completion date
November 30, 2016
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignancies, neoplasms